It was found that expression of SLC22A17 (HR = 1.58 (1.18–2.12), P = 0.0022) was associated with worse overall survival (OS) for gastric cancer patients,expression of SUPV3L1 (HR = 0.6 (0.45–0.8) P = 0.00034) was associated with good overall survival (OS) for gastric cancer patients (Fig. 2b). This evidence concerns the gene SUPV3L1 and gastric cancer.